go 6976 has been researched along with paclitaxel in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Aaltonen, V; Koivunen, J; Laato, M; Peltonen, J | 1 |
| Bastians, H; Ertych, N; Kienitz, A; Schneider, V; Stolz, A; Vogel, C; Yu, H | 1 |
3 other study(ies) available for go 6976 and paclitaxel
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
PKC inhibitor Go6976 induces mitosis and enhances doxorubicin-paclitaxel cytotoxicity in urinary bladder carcinoma cells.
Topics: Carbazoles; Cell Death; DNA Damage; Doxorubicin; Enzyme Inhibitors; G2 Phase; Humans; Indoles; Mitosis; Models, Biological; Paclitaxel; Protein Kinase C-alpha; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2007 |
Pharmacologic abrogation of the mitotic spindle checkpoint by an indolocarbazole discovered by cellular screening efficiently kills cancer cells.
Topics: Apoptosis; Aurora Kinase B; Aurora Kinases; Carbazoles; Chromosome Aberrations; Colonic Neoplasms; Drug Synergism; Enzyme Inhibitors; HCT116 Cells; Humans; Mitosis; Nocodazole; Paclitaxel; Protein Serine-Threonine Kinases; Spindle Apparatus | 2009 |